Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognitive impairment in multiple sclerosis.

Alexander Winkelmann1, Claudia Engel, Annett Apel

  • 1Department of Neurology, University of Rostock, Gehlsheimer Strasse 20, 18147, Rostock, Germany.

Journal of Neurology
|May 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal Study.

Neurology and therapy·2026
Same author

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same author

Rethinking EDSS-based ambulation assessment in multiple sclerosis using continuous variable monitoring.

Neurological research and practice·2026
Same author

Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.

The Lancet. Neurology·2026
Same author

Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases.

Therapeutic advances in neurological disorders·2025
Same author

Paediatric-onset multiple sclerosis: demographics, symptoms and disease progression.

Journal of neurology, neurosurgery, and psychiatry·2025

Multiple sclerosis (MS) frequently causes cognitive impairments, affecting memory, attention, and executive functions, significantly impacting daily life. While treatments like cognitive training exist, options remain limited for these complex neurological symptoms.

Area of Science:

  • Neuroscience
  • Neurology
  • Clinical Psychology

Background:

  • Cognitive dysfunctions affect up to 65% of multiple sclerosis (MS) patients.
  • Impairments commonly involve memory, attention, executive, and visual constructive functions.
  • These cognitive issues significantly reduce quality of life and work ability.

Purpose of the Study:

  • To detail cognitive functions and performance in MS patients.
  • To explore comorbidities like fatigue and depression.
  • To review current and potential therapeutic options for MS-related cognitive deficits.

Main Methods:

  • Literature review and synthesis of existing research on MS cognitive dysfunction.
  • Analysis of the relationship between cognitive impairment and disease progression.

Related Experiment Videos

  • Examination of treatment strategies including cognitive training and pharmacotherapy.

    • Main Results:

    • Cognitive dysfunctions are indicative of MS progression and neuronal network integrity.
    • Impairments, once developed post-relapse, tend to remain stable.
    • Comorbidities such as fatigue and depression exacerbate cognitive challenges.

    Conclusions:

    • Cognitive dysfunction is a major challenge in multiple sclerosis, impacting multiple life domains.
    • Early diagnosis and intervention are crucial for managing MS cognitive symptoms.
    • Further research is needed to expand effective treatment options beyond current cognitive training and limited pharmaceutical interventions.